Mental health and intellectual disability: the central clinical question
Mental health problems in people with intellectual disability are recognizable and treatable conditions whose identification requires attention to the person’s own experience, developmental and communication profile, changes from their usual functioning, physical health, and social environment. Intellectual disability concerns longstanding limitations in intellectual functioning and adaptive behavior beginning during development. Mental health conditions, by contrast, may arise at any point in life, fluctuate, recur, and respond to specific care. Accurate assessment therefore asks what has changed, why it has changed, what the person is experiencing, and which forms of treatment and support will help.
The central clinical task is to identify possible anxiety, depression, trauma-related difficulties, psychosis, bipolar disorder, and other psychiatric conditions without interpreting every sign of distress through intellectual disability alone. A person who becomes withdrawn, stops enjoying favorite activities, sleeps poorly, loses previously reliable daily skills, or displays new agitation deserves a meaningful clinical assessment. Such changes may indicate mental illness, pain, medication effects, adverse experiences, environmental distress, or several interacting factors. The NICE guideline on mental health problems in people with learning disabilities provides a detailed, multidisciplinary framework for recognizing and responding to these presentations.
In this article, “intellectual disability” is the principal American English term. The NICE guidance uses the UK expression “learning disabilities” for approximately the same clinical population; it does not mean only specific learning disorders such as dyslexia. The subject is psychiatric recognition and accessible treatment in intellectual disability. Assessment of the intellectual disability itself, or independent general treatments for particular psychiatric disorders, has its own clinical scope.
What intellectual disability changes in mental health care
The American Association on Intellectual and Developmental Disabilities defines intellectual disability by significant limitations in intellectual functioning and adaptive behavior, with onset during the developmental period. The relevant adaptive domains are conceptual, social, and practical functioning. Two people with the same diagnostic label can differ greatly in language, comprehension, sensory processing, independence, social support, and capacity to describe internal states. These differences affect how clinicians seek evidence of distress and adapt explanations, interviews, therapy, and follow-up.
Intellectual disability itself does not establish the presence of a psychiatric disorder. Equally, the existence of lifelong cognitive or adaptive limitations cannot explain away a newly emerging psychiatric syndrome. Clinical reasoning must distinguish the individual’s established developmental profile from current symptoms and from barriers created by particular settings. An apparent decline in self-care may reflect depression, an unrecognized seizure disorder, a disrupted support arrangement, or an acute physical illness; the immediate task is to investigate the change.
Communication is central. Some people can describe sadness, fear, voices, intrusive thoughts, or traumatic memories in their own words. Others express distress through behavior, facial expression, movement, sleep patterns, avoidance, changes in eating, or the need for additional prompting. People using augmentative and alternative communication should have access to their usual devices, symbols, communication partners, and enough time to respond. Supporters contribute observations while clinicians preserve the person’s own preferences, account, and participation.
How common are co-occurring mental health conditions?
Mental disorders are an important concern in intellectual disability, but a single headline prevalence percentage is scientifically misleading. Findings depend on diagnostic definitions, recruitment settings, severity of intellectual disability, co-occurring autism or genetic syndromes, the inclusion of challenging behavior in case definitions, and whether researchers use structured interviews, records, or informant ratings.
A 2026 umbrella review synthesized 26 systematic reviews, including seven meta-analyses, and reported substantial differences among psychiatric categories. Some estimates of schizophrenia, anxiety, and obsessive-compulsive disorders were higher than comparison estimates in the general population; estimates for certain mood and trauma-related categories appeared lower. The review judged the available studies to range from moderate to critically low quality and identified major gaps for specific ages, intellectual disability levels, and minority populations. These patterns describe differences in measured prevalence and diagnostic ascertainment, rather than a settled biological law about each condition. See Santambrogio and colleagues’ umbrella review.
What follows reliably is that psychiatric symptoms warrant active consideration and that neither a global prevalence estimate nor a diagnosis of intellectual disability can determine the probability of a particular disorder in an individual person. Clinicians need a longitudinal assessment and the usual disorder-specific diagnostic reasoning, adapted to the person’s communication and functioning.
Why psychiatric distress can be difficult to recognize
A change in functioning may be the first observable sign
New social withdrawal, increasing irritability, refusal of previously enjoyed activities, disrupted sleep, loss of appetite, reduced participation, repetitive reassurance-seeking, and unexplained agitation may prompt a mental health evaluation. In people with more substantial communication limitations, these changes can be more visible than direct reports of emotional symptoms. NICE specifically recommends considering mental health problems when there is a change in behavior, loss of skills, social withdrawal, avoidance, or loss of interest in normally enjoyed activities. NICE NG54, identification and referral.
A symptom becomes clinically meaningful through its trajectory, context, persistence, associated features, distress, and effect on everyday functioning. One sleepless night or one episode of aggression does not diagnose anxiety, depression, or psychosis. Consistent changes across several domains, particularly after a triggering event or with clear deterioration from baseline, justify a broader inquiry. Recording when difficulties occur, what precedes them, and how the person returns to comfort helps clinicians reconstruct the pattern.
Communication and interpretation affect what is observed
Clinical interviews often rely on abstract language: “hopeless,” “worthless,” “intrusive thoughts,” “delusions,” or “panic.” These questions require careful adaptation. Short sentences, concrete examples, familiar words, visual supports, and questions anchored to recent experiences can make information more accessible. Some people can communicate with speech yet have difficulty understanding complex questions or time frames. Agreement with the interviewer may reflect suggestibility, social pressure, or difficulty processing a question, so interviewers should use neutral prompts and check understanding.
An informant’s report adds information about sleep, activity, self-care, interpersonal contact, and signs noticed in familiar settings. It also carries limits. A caregiver may accurately recognize a profound change while misunderstanding the person’s emotional meaning. Staff turnover or disagreement between family and service providers can further complicate the picture. Clinicians should reconcile accounts against direct interaction, longitudinal records, and physical findings, rather than treating the loudest observer as the definitive historian. NICE NG54, assessment.
Diagnostic overshadowing is a specific clinical risk
Diagnostic overshadowing describes the attribution of potentially psychiatric symptoms to the known intellectual disability, with resulting failure to evaluate another condition adequately. It is an important diagnostic possibility, especially when new distress is dismissed as “part of the disability.” However, the empirical research does not show that this error occurs universally. A 2024 systematic review identified 25 studies, judged evidence quality low, and found that approximately one-third did not demonstrate overshadowing under their study conditions. The practical principle is to assess competing explanations openly and document why one is more convincing than another. Dell’Armo and Tassé, 2024.
The opposite error also matters: immediately labeling every expression of distress as a psychiatric disorder. A person who avoids meals because of dental pain, becomes agitated in an overwhelming environment, or withdraws after losing a trusted support worker needs the underlying problem addressed. Thorough assessment protects against both missed psychiatric illness and inappropriate psychiatric labeling.
Mental health conditions and possible presentations
Depression and loss of interest
Depression may involve persistently low mood or diminished interest together with changes in energy, sleep, appetite, psychomotor activity, concentration, self-evaluation, and thoughts of death. Where people can report emotional states, clinicians should ask about these directly in accessible language. For others, an observable pattern of reduced pleasure, tearfulness, social withdrawal, slowing, altered sleep, decreased participation, or loss of previously reliable skills may suggest depression. None of these behaviors is unique to depression, and assessment includes medical causes and life events.
Clinicians need to understand ordinary day-to-day functioning before interpreting changes. A person who has always needed assistance with dressing is different from a person who begins needing substantially more prompting after months of independent dressing. The presence of intellectual disability does not invalidate a depression diagnosis, while the standard diagnostic evidence may require developmentally sensitive interpretation. NICE recommends considering adapted cognitive behavioral therapy for depression and subthreshold depressive symptoms in people with milder intellectual disability. NICE NG54, psychological interventions.
Anxiety, fear, avoidance, and obsessive-compulsive symptoms
Anxiety can appear as expressed worry, fear in particular situations, persistent reassurance-seeking, physiological arousal, difficulties separating from trusted people, avoidance, or increased dependence on familiar routines. It can be associated with social stress, uncertainty, transitions, sensory environments, traumatic events, or co-occurring conditions. Clinicians should identify whether the pattern resembles a particular anxiety disorder, arises in an identifiable context, or reflects an immediate unmet need.
Obsessions and compulsions require special attention to meaning. Repetitive actions alone are insufficient for obsessive-compulsive disorder. Clinicians investigate whether repetitive thoughts or actions are unwanted, distressing, difficult to resist, and linked to feared outcomes, while accounting for the person’s communication and developmental profile. The interpretation of repetitive behavior also differs when co-occurring autism is present. NICE NG54.
Trauma-related difficulties
Exposure to abuse, bullying, restraint, frightening medical procedures, sudden separations, or other adverse events may affect safety, trust, sleep, arousal, avoidance, and behavior. A trauma assessment explores possible exposure without leading questions, respects the person’s communication needs, and establishes safeguards for disclosure. Sudden distress around specific people, places, or routines may be a reason to investigate, but it does not by itself demonstrate that abuse has occurred.
The availability and quality of trauma-specific measurement in intellectual disability remain uneven. The 2023 review of adult mental health instruments identified some promising measures, including tools for traumatic stress, while emphasizing incomplete psychometric evaluation. Diagnosis of a trauma-related disorder therefore requires a skilled assessment of symptoms, exposure, impairment, and alternative explanations, rather than a score alone. Patel, Lee, and Scior, 2023.
Psychosis and bipolar symptoms
Possible psychotic symptoms merit prompt specialist assessment. Asking about unusual perceptual experiences requires attention to developmental language, imagination, sleep-related experiences, culturally meaningful beliefs, trauma, and the person’s interpretation. Statements that sound unusual in a brief interview should be explored in context before being classified as hallucinations or delusions. A consistent change in reality testing, behavior, emotional expression, or functioning may be more informative than a single ambiguous answer.
Possible mania is more than a period of agitation or hyperactivity. Clinicians look for a distinct episode involving a significant change in mood or energy, reduced need for sleep, marked activation, altered judgment, and other syndrome-specific features. Medication effects, seizures, sleep deprivation, and environmental changes can resemble parts of this picture. Suspected serious mental illness calls for assessment by a psychiatrist with appropriate intellectual disability expertise, consistent with NICE NG54.
Mental health in people with more severe communication limitations
For some people with severe or profound intellectual disability, the clinical signal comes primarily through changes in behavior, body language, physiological patterns, and the observations of familiar supporters. The challenge is to take those signals seriously while guarding against overinterpretation. Reviews of measures for severe or profound intellectual disability found a limited number of instruments with adequate evidence and emphasized the need for replication and better approaches to measuring well-being directly. Flynn and colleagues, 2017.
Specialist assessment often involves extended observation, attention to pain and physical conditions, comparison with familiar routines, communication assessment, and careful documentation of possible episodes. A usable outcome might be improvement in sleep, return to preferred activities, reduced distress during care, or the ability to communicate choices. The measured outcome should connect to the individual’s priorities and the hypothesis being tested.
Physical conditions, medication, and environmental causes
A high-quality mental health assessment starts with a broad differential diagnosis. Pain from dental disease, constipation, reflux, urinary problems, musculoskeletal injury, menstrual symptoms, or other medical conditions may change behavior or mood. Sleep disorders, sensory loss, epilepsy, adverse medication effects, and changes in neurological functioning can complicate recognition. A new change in consciousness, sudden confusion, acute neurological symptoms, or severe behavioral change with physical illness calls for urgent medical evaluation rather than routine psychiatric labeling.
Medication lists should include prescribed drugs, recently started or stopped treatments, and relevant over-the-counter products. Sedation, movement disorders, activation, anticholinergic effects, or drug interactions can alter participation and distress. Review medication changes against the symptom timeline and seek advice from the relevant prescriber, especially where epilepsy treatment or several psychotropic drugs are involved. NICE NG54, pharmacological interventions.
The ecological context is equally important. Housing instability, inaccessible communication, a restrictive daily schedule, under-stimulation, sensory overload, loss of relationships, stigma, bullying, and difficulty exercising choice can contribute to distress. Social determinants are part of the clinical formulation because treatment effectiveness depends in part on whether the conditions sustaining distress are addressed. A person-centered plan should include environmental changes where they are indicated.
A structured diagnostic pathway
Begin with an accessible first conversation
The clinician should address the person directly, establish their preferred communication method, ask about immediate concerns, and explain why the evaluation is taking place. Information can be provided using plain language, visual materials, short appointments, breaks, demonstration, or supported communication. The person’s consent and participation should be addressed through applicable law and clinical standards; decision-making abilities must be considered in relation to the specific choice and available support.
The first appointment should establish what the person wants help with and how they define improvement. It should also identify immediate safety risks, possible medical urgency, and whether the current environment can support an appropriate assessment. For someone who cannot readily describe emotional symptoms, a familiar person may help explain the usual routines and recent changes while the clinician still observes and communicates with the person directly.
Establish baseline and symptom timeline
Assessment distinguishes enduring characteristics from recent changes. Useful baseline information includes usual sleep and eating, preferred activities, language and communication patterns, self-care, friendships, work or school participation, typical coping responses, and how the person shows discomfort. A timeline then records onset, duration, fluctuation, possible triggers, medical events, medication changes, and the effect of support changes.
A clinician may use several sources: the person’s account, family members or chosen supporters, teachers or service staff, clinical records, primary-care information, and direct observation. Agreement among sources increases confidence, while disagreement highlights questions to resolve. The record should distinguish direct observations from interpretations: “cried on five evenings and stopped attending the art group” is more precise than “became manipulative” or “acted mentally ill.”
Conduct a comprehensive psychiatric and medical evaluation
A full evaluation addresses mood, anxiety, psychotic experiences, trauma exposure where clinically relevant, behavioral change, sleep, substance use when applicable, social circumstances, safeguarding, past psychiatric episodes, and treatments. Physical health, sensory functioning, pain, medication, and neurological history are reviewed. The clinician applies an appropriate diagnostic classification and documents uncertainty when information is insufficient. NICE recommends evaluation by professionals experienced in intellectual disability and access to other specialties as necessary. NICE NG54, assessment.
Screening instruments can help structure observations and track change, but they do not establish diagnoses in isolation. They must be selected for the person’s age, communication, intellectual functioning, language, and context. A clinician should check whether the measure has adequate validation for the intended group and purpose. An instrument validated for adults with milder intellectual disability cannot automatically be assumed valid for a child or someone with profound intellectual disability.
Use assessment tools as aids, with a clear purpose
For children and adolescents, the Developmental Behavior Checklist and the Strengths and Difficulties Questionnaire are among measures discussed in the NICE recommendations. A systematic review of 49 studies found more consistently documented psychometric support for tools designed specifically for children and adolescents with intellectual disability than for general-population tools. This is a group-level finding, not a claim that every disability-specific instrument is superior in every clinical situation. Halvorsen and colleagues, 2023.
For adults, measures such as the Glasgow Depression Scale, adapted anxiety and trauma instruments, informant-report scales, and PAS-ADD approaches may be considered according to clinical purpose and accessibility. A 2023 systematic review found promising properties for selected measures but also substantial gaps in validity and replication. Scores are most useful when interpreted alongside clinical history and the person's account, and where possible when repeated to monitor the same target over time. Patel, Lee, and Scior, 2023.
Formulate the problem, rather than assigning a label prematurely
A clinical formulation integrates developmental vulnerabilities, current psychiatric symptoms, physical health, psychological stressors, relationships, communication, and environmental contingencies. It distinguishes what likely predisposed the person to distress, what triggered a change, which factors maintain it, and what protects or helps the person. The formulation should specify which hypotheses are well supported and what additional information would change the diagnosis.
For example, a person may become withdrawn after a move, develop fragmented sleep, and avoid a previously enjoyed activity. The possible explanations include depression, grief, anxiety, sleep disruption, pain, loss of familiar communication supports, and combinations of these. A useful assessment tests these possibilities through history, examination, accessible conversation, and carefully monitored interventions. The formulation is revised as new evidence arrives.
Challenging behavior and psychiatric diagnosis
Aggression, self-injury, property damage, elopement, or refusal of activities describes observable behavior. These events can accompany mental illness, pain, frustration, trauma, inaccessible environments, communication difficulties, or learned patterns of interaction. A behavioral event is therefore a clinical and functional signal requiring explanation, not an automatic psychiatric diagnosis. A specific pattern may justify immediate protective action, yet treatment planning still depends on determining what contributes to it.
Behavioral assessment can examine antecedents, consequences, setting events, communication opportunities, unmet needs, and patterns across contexts. This approach complements rather than replaces psychiatric and physical assessment. Its goal is to understand why behavior occurs, identify preventable triggers, strengthen communication and coping, and improve the person’s access to preferred activities and relationships. The NICE guideline on behavior that challenges recommends individualized, multidisciplinary intervention and careful restrictions on antipsychotic use for behavior alone.
When self-injury is occurring, immediate injury prevention and medical evaluation take priority. The presence of self-injury does not specify suicidal intent; some behavior is repetitive or arises in response to pain or communication barriers. Conversely, possible suicidal thoughts or plans must be taken seriously even when a person has intellectual disability or communication limitations. Risk assessment explores intent, available means, recent stressors, ability to communicate distress, protective relationships, and the support required for safety.
Evidence-based treatment and treatment adaptation
Accessible psychological care
People with intellectual disability can benefit from psychological treatment when it is matched to their needs, preferences, and abilities. Adaptation may involve simpler language, concrete examples, visual supports, rehearsal, a slower pace, shorter sessions, repetition, supported practice between sessions, and involvement of a trusted person when the patient wants that support. These strategies address access to treatment; the clinician still needs a clear problem formulation and an evidence-informed therapeutic model.
NICE recommends adapting psychological treatment on the basis of assessment, considering modified cognitive behavioral therapy for depression in people with milder intellectual disability, and considering relaxation or graded exposure techniques for some anxiety presentations. Selection must account for the person’s communication, cognitive profile, diagnosis, treatment history, and preference. NICE NG54, interventions.
A 2023 meta-analysis of 33 controlled trials, with 19 included in quantitative synthesis, found an overall small positive effect of psychological therapy after specified outlier exclusions. Methodological weaknesses were substantial: many samples were small, trial designs varied, and reporting quality was often low. Results for depression and anxiety were less definitive in subgroup analysis than the pooled headline result. The evidence supports offering appropriately adapted psychological approaches while measuring outcomes and recognizing uncertainty about comparative effectiveness for particular conditions and groups. Tapp and colleagues, 2023.
Medication for an identified psychiatric condition
Medication can be clinically appropriate for a diagnosed psychiatric disorder when a clinician weighs expected benefits, adverse effects, co-occurring medical conditions, interactions, patient preferences, and available alternatives. Prescribing should follow condition-specific guidance adapted to the person’s health and communication profile. A recorded target symptom, rationale, monitoring plan, and review date make treatment safer and more accountable. For children and people with more severe intellectual disability, specialist involvement is particularly important. NICE NG54, pharmacological interventions.
Antipsychotic drugs should not become an indefinite response to unexplained behavioral distress. NICE recommends considering antipsychotics for behavior that challenges only under restricted circumstances, alongside psychological or other interventions, with documented target behavior and active review of benefit and harm. NHS England’s STOMP and STAMP program emphasizes appropriate indications, the minimum effective dose, regular structured medication review, and reducing inappropriate psychotropic prescribing. This framework supports individualized prescribing and careful deprescribing when appropriate, rather than abrupt, unsupervised cessation.
Relevant adverse effects depend on the drug and can include sedation, weight and metabolic changes, movement symptoms, cardiac effects, constipation, and interactions with anti-seizure medication. Patients and supporters should know what is being monitored and whom to contact about new symptoms. Any medication change, especially reduction of long-term psychotropics, requires coordination with the responsible clinician and an assessment of withdrawal or relapse risks.
Social, behavioral, occupational, and environmental interventions
Psychiatric treatment works best when combined with supports that make daily life more predictable, communicative, meaningful, and self-directed. Depending on the person’s needs, this can include safer living conditions, reduced sensory stress, reliable routines, communication access, chosen social activities, meaningful work or education, staff training, help with sleep, and timely treatment of pain. These strategies have direct value for participation even when they are not a stand-alone treatment for a psychiatric disorder.
A person-centered care plan identifies who will carry out each action, which outcomes matter to the person, how treatment and services coordinate, and when the plan will be reviewed. Family members, supporters, and care workers can contribute to implementation while respecting privacy and the individual’s choices. NICE emphasizes coordinated access to mental health and disability expertise and clear shared responsibilities. NICE NG54, organization and care planning.
Acute distress, psychosis, suicidal risk, and safeguarding
Acute safety concerns require proportionate clinical action and rapid access to qualified services. Indicators may include expressed suicidal intent, a recent attempt, an immediate threat of serious harm, suspected psychosis with severe deterioration, prolonged inability to sleep with marked behavioral activation, severe self-injury, or abrupt confusion associated with illness. Emergency medical services should be contacted when there is imminent danger or a serious medical emergency. A caregiver or clinician should not rely on internet descriptions or a screening questionnaire to manage an immediate crisis.
Risk assessment should be accessible and individualized. A person may need visual communication aids, direct concrete questions, additional processing time, or an advocate. Clinicians should consider the person’s understanding of death and self-harm, possible impulsivity, current supervision, access to means, and signs of an underlying condition. Clear safety planning includes practical supports, communication methods, review responsibility, and the least restrictive setting compatible with safety.
Safeguarding includes reasonable investigation of possible abuse, coercion, neglect, and exploitation. Disclosure may emerge indirectly, and the person may need a specialized interviewing approach. Information should be gathered without coaching or suggestive questioning and managed under applicable safeguarding law and professional procedures. Psychotropic sedation must never substitute for protection from harmful circumstances.
Children, adolescents, adults, and older people
In children and adolescents, emotional and behavioral symptoms unfold alongside communication, education, family life, identity, and changing expectations. A child may express anxiety through avoidance, distress during transitions, or sleep disruption; clinicians also evaluate bullying, sensory stress, learning environments, parent-child relationships, physical health, and co-occurring developmental conditions. Parent or caregiver interventions may be useful when they improve communication and coping, while care should continue to center the young person’s needs and developmental capacities. NICE NG54.
In adulthood, changes in housing, employment, relationships, community access, and support arrangements can shape vulnerability or resilience. Diagnostic evaluation should include consent, meaningful choice, the quality of daily routines, and whether the person has opportunities to report distress privately. It is particularly important to distinguish new mental illness from dissatisfaction, grief, social isolation, or preventable environmental stress, even when these factors coexist with a diagnosable condition.
In later life, psychiatric symptoms, chronic illness, sensory impairment, adverse drug effects, and emerging neurocognitive disease may overlap. For people with Down syndrome or other relevant conditions, changes from a well-documented lifelong baseline are essential when evaluating possible dementia. New confusion or functional decline should receive medical investigation; it cannot be classified as aging or depression from observation alone. NICE recommends particular attention to new functional and behavioral change during health checks for adults with Down syndrome. NICE NG54, annual health checks.
Participation, supported decision-making, and quality of life
A person’s participation in mental health care is part of treatment quality. Accessible information, supported decisions, attention to personal values, and an agreed method of communicating preferences make treatment more responsive and can improve engagement. Decision-making support may involve simplified choices, opportunities to ask questions, independent advocacy, and time to consider options. Legal rules vary across jurisdictions, but the clinical expectation of respect, individualized capacity consideration, and participation is broadly applicable.
Treatment outcomes need to reach beyond symptom scores. Important changes may include restored interest in chosen activities, improved sleep and comfort, reduced avoidable restrictions, stronger relationships, access to education or employment, better communication, and a greater sense of security and self-determination. Outcome selection should be discussed with the person and, when appropriate, their chosen supporters.
The broad developmental and support framework is discussed in Cluster Intellectual and Developmental Disabilities. The interaction between co-occurring autism and intellectual disability has a different, specifically owned clinical question, developed in Autism and Intellectual Disability in Adults: Differences and Support.
What the research establishes and what remains uncertain
Established clinical principles include the need to assess psychiatric conditions on their own merits, compare current problems with an individual baseline, consider physical health and medication effects, communicate accessibly, and coordinate professional expertise. Guidance also supports the use of appropriately adapted treatment pathways and periodic review of outcomes. These conclusions are supported by major professional guidance, although the strength of direct intervention trials varies across age and support-need groups. NICE NG54.
More preliminary or limited findings concern precise disorder prevalence in narrowly defined subpopulations, the relative accuracy of particular screening instruments, and the comparative benefits of specific psychotherapy adaptations. The 2026 umbrella review identified major epidemiological quality problems; systematic reviews of instruments found incomplete psychometric evidence; and controlled psychotherapy trials have often been too small or heterogeneous to establish confident subgroup-specific estimates. These limitations matter because a single score or pooled effect size can conceal important differences in communication profile, psychiatric syndrome, and level of support. Santambrogio et al., 2026; Patel et al., 2023; Tapp et al., 2023.
Contested claims should be stated as such. Diagnostic overshadowing describes a credible clinical mechanism, but the frequency and generalizability of observed bias remain uncertain. Claims that people with intellectual disability cannot benefit from psychotherapy, that all challenging behavior signifies psychiatric illness, or that psychotropic medication is never indicated do not follow from the evidence. A high-quality service tests its decisions against individual outcomes and revises them when the evidence changes.
Practical questions about mental health and intellectual disability
Can someone have intellectual disability and a separate psychiatric diagnosis?
Yes. Intellectual disability describes a developmental profile of intellectual and adaptive limitations; psychiatric conditions such as depression, anxiety disorders, or psychosis can occur in the same person. Diagnosis requires evaluation of the specific psychiatric condition and its effects, taking account of communication and lifelong functioning.
How can a family or support worker recognize a possible mental health problem?
Look for changes from the person’s usual pattern: lost interest, withdrawal, disrupted sleep or eating, sustained fear, unexplained distress, more prompting to carry out familiar activities, or marked agitation. Document examples and the time course, ask the person what is happening using their preferred communication, and seek a professional evaluation that also considers physical health. NICE NG54.
Does aggressive behavior mean someone has a psychiatric disorder?
No single behavior proves a psychiatric diagnosis. Aggression may accompany psychiatric symptoms, pain, communication barriers, changes in surroundings, or several interacting factors. Evaluation should consider immediate safety, medical conditions, mental health, and the behavior’s context before selecting an intervention.
Is psychological therapy possible when someone has limited verbal language?
Treatment can be adapted using concrete language, visual communication, repetition, supported practice, and accessible goals. The choice of therapy must reflect a careful assessment, and the evidence base is more developed for some groups and conditions than for others. The person’s comfort, preference, and ability to participate should be part of the treatment plan. Tapp et al., 2023.
Can screening questionnaires establish the diagnosis?
Screening and symptom rating tools can indicate the need for further assessment or help track change. Diagnostic conclusions require a clinical assessment that considers symptoms, duration, impairment, developmental context, medical causes, and collateral information. Tools should have appropriate psychometric support for the intended population. Halvorsen et al., 2023.
When is specialist or urgent assessment necessary?
Suspected serious mental illness, psychosis, major unexplained functional deterioration, complex medication problems, and possible dementia warrant specialist review. Immediate danger of suicide, severe self-injury, acute confusion, or serious physical illness calls for urgent local emergency evaluation. The assessment must remain accessible to the person and include the support they need to communicate. NICE NG54.
Clinical synthesis
Effective mental health care for people with intellectual disability follows a coherent pathway: notice meaningful change, listen using the person’s preferred communication, reconstruct the individual baseline, assess physical and psychiatric explanations, develop a collaborative formulation, select accessible treatment, and measure outcomes that matter in everyday life. The diagnosis of intellectual disability informs how care is delivered; it does not predetermine what a person is feeling or which treatment will work. The strongest practice combines psychiatric expertise with communication access, respect for the person's choices, skilled medical assessment, and coordinated long-term support.
Related Articles
Autism and Intellectual Disability in Adults: Differences and Support — A focused examination of distinct and co-occurring conditions in adulthood, with their implications for assessment and support.
Self-Injurious Behavior in Intellectual Disability: Risk Assessment and Support — Specialist assessment and safeguarding for repetitive self-injurious behavior.
Diagnostic Overshadowing in Intellectual Disability: How Conditions Are Missed — Assessment bias and strength of research evidence specific to ID.
References
American Association on Intellectual and Developmental Disabilities. (2021). Defining criteria for intellectual disability. AAIDD.
Dell’Armo, K., and Tassé, M. J. (2024). Diagnostic overshadowing of psychological disorders in people with intellectual disability: A systematic review. American Journal on Intellectual and Developmental Disabilities, 129(2), 116–134.
Flynn, S., Vereenooghe, L., Hastings, R. P., Adams, D., Cooper, S.-A., Gore, N., Hatton, C., Hood, K., Jahoda, A., Langdon, P. E., McNamara, R., Oliver, C., Roy, A., Totsika, V., and Waite, J. (2017). Measurement tools for mental health problems and mental well-being in people with severe or profound intellectual disabilities: A systematic review. Clinical Psychology Review, 57, 32–44.
Halvorsen, M. B., Helverschou, S. B., Axelsdottir, B., Brøndbo, P. H., and Martinussen, M. (2023). General measurement tools for assessing mental health problems among children and adolescents with an intellectual disability: A systematic review. Journal of Autism and Developmental Disorders, 53, 132–204.
National Health Service England. (2025). Stopping over medication of people with a learning disability and autistic people (STOMP) and supporting treatment and appropriate medication in paediatrics (STAMP). NHS England.
National Institute for Health and Care Excellence. (2015). Challenging behaviour and learning disabilities: Prevention and interventions for people with learning disabilities whose behaviour challenges (NG11). NICE.
National Institute for Health and Care Excellence. (2016; reviewed 2024). Mental health problems in people with learning disabilities: Prevention, assessment and management (NG54). NICE.
Patel, M., Lee, J. Y., and Scior, K. (2023). Psychometric properties of measures designed to assess common mental health problems and wellbeing in adults with intellectual disabilities: A systematic review. Journal of Intellectual Disability Research, 67(5), 397–414.
Santambrogio, J., Boido, G., Marchetti, M., Rudra, S., Besana, F., Francia, E., Terrevazzi, S., Papola, D., Barbui, C., Bertelli, M., Clerici, M., D’Agostino, A., Marston, L., and Hassiotis, A. (2026). Prevalence of mental disorders in people with intellectual disabilities across the lifespan: Umbrella review. BJPsych Open, 12(3), e139.
Tapp, K., Vereenooghe, L., Hewitt, O., Scripps, E., Gray, K. M., and Langdon, P. E. (2023). Psychological therapies for people with intellectual disabilities: An updated systematic review and meta-analysis. Comprehensive Psychiatry, 122, 152372.